A Phase II Study of Neoadjuvant Chemotherapy With and Without Trastuzumab in Patients With Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2018
At a glance
- Drugs Trastuzumab (Primary) ; Cyclophosphamide; Doxorubicin; Paclitaxel
- Indications Advanced breast cancer; Breast cancer
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 05 Nov 2018 Planned End Date changed from 1 Dec 2019 to 1 Dec 2022.
- 05 Nov 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.
- 31 Aug 2018 Biomarkers information updated